KIR3DL1 and Miyoshi myopathy: In the only two other retrospective studies concerning haploSCT with PTCY in MM where there was no selection on KIR-mismatch, comparable results were seen with respect to NRM (10–21% in 1.5 to 2 years); however, they had a slightly higher PFS (17–33% in 1.5 to 2 years).